Vimarsana
Biggest News Aggregation in the World

Chapter 11 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Chapter 11. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Chapter 11 Today - Breaking & Trending Today

Medical Center of SETX parent company files for bankruptcy, remains open serving patients - Vimarsana News

Medical Center of SETX parent company files for bankruptcy, remains open serving patients

From Steward Health Care - Today, Steward Health Care (“the Company”), a national fully integrated value-based healthcare system and the largest physician-led h

Source: kfdm.com
Adam Neumann Offers to Buy Back WeWork for More Than $500 Million, WSJ Reports - Vimarsana News

Adam Neumann Offers to Buy Back WeWork for More Than $500 Million, WSJ Reports

WeWork co-founder Adam Neumann has submitted an offer to buy the bankrupt company for more than $500 million, the Wall Street Journal reported, citing people with knowledge of the matter.

Independent examiner ordered in the bankruptcy case of FTX - Vimarsana News

Independent examiner ordered in the bankruptcy case of FTX

A federal appeals court has ordered the appointment of an independent examiner in the bankruptcy case of FTX

Source: kcra.com
Terraform Labs: Terraform Labs files for bankruptcy protection in US - Vimarsana News

Terraform Labs: Terraform Labs files for bankruptcy protection in US

Singapore-based Terraform labs, in a filing with the bankruptcy court in Delaware, listed assets and liabilities in the range of $100-$500 million. Recently, a federal judge postponed the trial of the U.S. Securities and Exchange Commission (SEC) against the company and its co-founder, Do Kwon, over an alleged $40 billion cryptocurrency fraud.

EXPLAINER | How will the Supreme Court reshape US opioid epidemic relief? - Vimarsana News

EXPLAINER | How will the Supreme Court reshape US opioid epidemic relief?

President Joe Biden’s administration has argued that Purdue Pharma’s settlement is an abuse of bankruptcy protections